The CRO landscape is changing, but not in the way most people think

Understanding how small molecules interact with their protein targets, and importantly, their off-targets, is one of the biggest challenges in drug discovery.

Class B GPCRs are playing an increasingly important role in modern drug discovery, particularly in metabolic, endocrine, and obesity-related programs.

Discover why ADCC, CDC, and ADCP cytotoxicity assays are essential for proving antibody mechanism of action and ensuring safety

Kinase drug discovery is complex due to conserved ATP binding pockets and high structural homology, making selectivity and mechanism of action assessment particularly challenging.